Moreover, DPP-4 inhibitors were shown to prevent the biologically active form of the chemokine CXCL10 from being truncated by DPP-4, and CXCL10 then enhanced NK and T cell chemotaxis toward HCC cells, resulting in an antitumor effect (21). Here, CXCL10 is linked to hepatocellular carcinoma.